18 June 2002
Human leptin administered intraperitoneally stimulates natriuresis and decreasesrenal medullary Na+, K+-ATPase activity in the rat - impaired effect in dietary-induced obesity.
Grazyna W jcicka, Jerzy Bełtowski, Dionizy Górny, Andrzej MarciniakMed Sci Monit 2002; 8(6): BR221-229 :: ID: 420820
Abstract
BACKGROUND: Leptin, produced by adipose tissue, apart from regulating foodintake and energy expenditure, also has natriuretic activity. In this study we examined the effect ofleptin on renal Na+, K+-ATPase responsible for active tubular sodium reabsorption, and compared the renaleffects of leptin in lean and obese rats.MATERIAL/METHODS: Male Wistar rats were either kept on normallaboratory chow or made obese by a high-calorie diet. The animals were placed in metabolic cages andurine was collected in 2-hour periods.RESULTS: In lean animals, leptin (1 mg/kg i.p.) caused a 139.5%increase in urine output, a 112.4% increase in natriuresis, and a 57.2% increase in the fractional excretionof sodium, but had no effect on the glomerular filtration rate. Leptin at this dose decreased renal medullaryNa+, K+-ATPase activity at 30 minutes, 1 hour and 2 hours by 31%, 34.3% and 21.2%, respectively. Theeffect of leptin on Na+, K+-ATPase at 1 hour was dose-dependent; the lowest dose inducing significantinhibition was 0.25 mg/kg. By contrast, leptin had no effect on either cortical Na+, K+-ATPase or theouabain-resistant fraction of ATPase. In obese rats, leptin increased urine output by only 29.1% andnatriuresis by 28.9%, and had no significant effect on medullary Na+, K+-ATPase.CONCLUSIONS: Leptin stimulatesnatriuresis primarily by inhibiting tubular sodium reabsorption. This effect is mediated, at least partially,by decreased Na+, K+-ATPase activity in the renal medulla, and is impaired in obese rats.
Keywords: Blood Pressure, Diet, Injections, Intraperitoneal, Kidney Medulla, Leptin, Na(+)-K(+)-Exchanging ATPase, Natriuresis, Obesity, Rats, Wistar, Research Support, Non-U.S. Gov
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952